Page last updated: 2024-08-05 12:33:44
aflatoxin
Any of a group of related and highly toxic secondary metabolites (mycotoxins) whose main structural feature is a fused coumarin-bis(dihydrofuran) ring system and which are produced by strains of the moulds Aspergillus flavus or A. parasiticus, together with further metabolites of these mycotoxins
ChEBI ID: 22271
Members (5)
| Member | Definition | Role |
|---|---|---|
| aflatoxin b | An aflatoxin having a hexahydrocyclopenta[c]furo[3',2':4,5]furo[2,3-h]chromene skeleton with oxygen functionality at positions 1, 4 and 11. | aflatoxin B2 |
| aflatoxin b1 | An aflatoxin having a tetrahydrocyclopenta[c]furo[3',2':4,5]furo[2,3-h]chromene skeleton with oxygen functionality at positions 1, 4 and 11. | aflatoxin B1 |
| aflatoxin b1-2,3-oxide | aflatoxin B1 exo-8,9-epoxide | |
| aflatoxin m1 | A member of the class of aflatoxins that is aflatoxin B1 in which the hydrogen at position 9a is replaced by a hydroxy group. | aflatoxin M1 |
| aflatoxin q1 | A member of the class of aflatoxins that is aflatoxin B1 in which the hydrogen at the pro-3S position is replaced by a hydroxy group. | aflatoxin Q1 |
Research
Studies (4,677)
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 908 (19.41) | 18.7374 |
| 1990's | 884 (18.90) | 18.2507 |
| 2000's | 817 (17.47) | 29.6817 |
| 2010's | 1,322 (28.27) | 24.3611 |
| 2020's | 746 (15.95) | 2.80 |
Study Types
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 58 (1.07%) | 5.53% |
| Reviews | 228 (4.20%) | 6.00% |
| Case Studies | 8 (0.15%) | 4.05% |
| Observational | 1 (0.02%) | 0.25% |
| Other | 5,133 (94.57%) | 84.16% |